F Audibert

679 total citations
17 papers, 531 citations indexed

About

F Audibert is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, F Audibert has authored 17 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in F Audibert's work include Immune Response and Inflammation (4 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). F Audibert is often cited by papers focused on Immune Response and Inflammation (4 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). F Audibert collaborates with scholars based in France and United States. F Audibert's co-authors include L Chedid, J Choay, P. Lefrancier, E. Lederer, François Parant, M Parant, C Carelli, Michael Sela, Claude Leclerc and C Bona and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The FASEB Journal and Infection and Immunity.

In The Last Decade

F Audibert

17 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F Audibert France	9	267	199	120	113	62	17	531
Francine Parant France	9	309 1.2×	151 0.8×	127 1.1×	89 0.8×	40 0.6×	11	522
G. H. Christie United Kingdom	15	422 1.6×	111 0.6×	58 0.5×	155 1.4×	59 1.0×	19	757
Aline Blaecke France	9	471 1.8×	237 1.2×	65 0.5×	113 1.0×	112 1.8×	9	822
Leona Wurz United States	8	261 1.0×	157 0.8×	41 0.3×	68 0.6×	25 0.4×	10	661
Dominique Juy France	10	276 1.0×	119 0.6×	54 0.5×	50 0.4×	31 0.5×	25	409
Joachim L. Weickmann United States	12	179 0.7×	428 2.2×	107 0.9×	61 0.5×	38 0.6×	15	672
R. W. Ferraresi United States	12	209 0.8×	118 0.6×	38 0.3×	59 0.5×	50 0.8×	27	501
R. Parker United States	13	184 0.7×	106 0.5×	25 0.2×	98 0.9×	45 0.7×	17	403
D L Peavy United States	13	388 1.5×	145 0.7×	26 0.2×	81 0.7×	56 0.9×	16	609
Robert M. Fauve France	11	238 0.9×	119 0.6×	17 0.1×	78 0.7×	78 1.3×	38	570

Countries citing papers authored by F Audibert

Since Specialization

Citations

This map shows the geographic impact of F Audibert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Audibert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Audibert more than expected).

Fields of papers citing papers by F Audibert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Audibert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Audibert. The network helps show where F Audibert may publish in the future.

Co-authorship network of co-authors of F Audibert

This figure shows the co-authorship network connecting the top 25 collaborators of F Audibert. A scholar is included among the top collaborators of F Audibert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Audibert. F Audibert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Vogel, Frederick R., F Audibert, & L Chedid. (1989). Suppression of in vitro lymphocyte function by cks 17 a synthetic retroviral envelope peptide modulation of suppression by muramyl dipeptide mdp. The FASEB Journal. 3(4). 1118. 1 indexed citations

Chedid, L, F Audibert, M. Jolivet, et al.. (1984). Epitope specific immunity elicited by totally synthetic monovalent or polyvalent vaccines.. PubMed. 1(2). 77–85. 2 indexed citations

Audibert, F, Grzegorz Przewlocki, P. Lefrancier, J Choay, & L Chedid. (1982). [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].. PubMed. 295(10). 611–4. 2 indexed citations

Carelli, C, F Audibert, & L Chedid. (1981). Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil. Infection and Immunity. 33(1). 312–314. 18 indexed citations

Chedid, L, C Carelli, & F Audibert. (1979). Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.. PubMed. 26(Suppl). 631–41. 36 indexed citations

Audibert, F, et al.. (1979). [Effects of mycobacterial hydrosoluble adjuvants on the induction and prevention of experimental autoimmune uveo-retinitis in guinea-pigs (author's transl)].. PubMed. 130C(1). 29–32. 2 indexed citations

Chedid, L, M Parant, François Parant, et al.. (1979). Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.. Proceedings of the National Academy of Sciences. 76(12). 6557–6561. 57 indexed citations

Leclerc, Claude, F Audibert, & L Chedid. (1978). Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.. PubMed. 35(6). 963–70. 25 indexed citations

Parant, M, F Audibert, François Parant, et al.. (1978). Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor). Infection and Immunity. 20(1). 12–19. 37 indexed citations

10.

Johnson, Arthur G., F Audibert, & L Chedid. (1978). Synthetic immunoregulating molecules: A potential bridge between cytostatic chemotherapy and immunotherapy of cancer. Cancer Immunology Immunotherapy. 3(4). 10 indexed citations

11.

Chedid, L, F Audibert, P. Lefrancier, J Choay, & E. Lederer. (1976). Modulation of the immune response by a synthetic adjuvant and analogs.. Proceedings of the National Academy of Sciences. 73(7). 2472–2475. 168 indexed citations

12.

Audibert, F & L Chedid. (1976). Activity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvant. Infection and Immunity. 14(6). 1263–1268. 2 indexed citations

13.

Audibert, F, L Chedid, P. Lefrancier, & J Choay. (1976). Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cellular Immunology. 21(2). 243–249. 127 indexed citations

14.

Audibert, F, et al.. (1975). [Adjuvant and mitogenic effects of detoxified lipopolysaccharides].. PubMed. 280(9). 1197–200. 4 indexed citations

15.

Chedid, L, F Audibert, C Bona, et al.. (1975). Biological activities of endotoxins detoxified by alkylation. Infection and Immunity. 12(4). 714–721. 35 indexed citations

16.

Audibert, F, et al.. (1974). [Use of a water-soluble adjuvant fraction from "Mycobacterium smegmatis" with sperm extract to induce autoimmune aspermatogenic orchiepididymitis in guniea pigs (author's transl)].. PubMed. 125(6). 901–10. 2 indexed citations

17.

Audibert, F & G Sándor. (1968). [Nature of the antitoxin fraction of horse immune serums].. PubMed. 267(4). 457–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact